KELLY GLISSON: Open Payments
NPI 1144635376 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,481 in 122 payments from 24 companies in 2025. Trend: 2023 $2,588 · 2024 $21,631 · 2025 $2,481
Food & beverage: $2,361Long term medical supply or device loan: $120
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 20 | $400 |
| Novo Nordisk Inc | 20 | $392 |
| Abbott Laboratories | 15 | $280 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $258 |
| Ascendis Pharma Endocrinology Inc | 5 | $197 |
| IBSA Pharma Inc. | 5 | $105 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $79 |
| Corcept Therapeutics | 4 | $77 |
| Radius Health, Inc. | 4 | $71 |
Products named: JARDIANCE, Wegovy, MOUNJARO, Yorvipath, FREESTYLE LIBRE 3, FREESTYLE COPILOT, Tirosint, ISTURISA.
Industry payments across NC — which companies pay providers there.
